Eton Pharmaceuticals Inc (ETON)
10.73
+0.13
(+1.23%)
USD |
NASDAQ |
Nov 14, 11:16
Eton Pharmaceuticals Revenue (Annual): 31.64M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 31.64M |
December 31, 2022 | 21.25M |
December 31, 2021 | 21.83M |
Date | Value |
---|---|
December 31, 2020 | 0.039M |
December 31, 2019 | 0.959M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.039M
Minimum
2020
31.64M
Maximum
2023
15.14M
Average
21.25M
Median
2022
Revenue (Annual) Benchmarks
Biomarin Pharmaceutical Inc | 2.419B |
Integra Lifesciences Holdings Corp | 1.542B |
Elutia Inc | 24.74M |
Immuneering Corp | -- |
Journey Medical Corp | 79.18M |